Guselkumab Efficacy in Psoriatic Arthritis Assessed by Multi-Domain Composite Indices: Data from the Phase 3b COSMOS Trial in a TNFi-IR Population

67 views
June 30, 2022
0 Comments
Login to view comments. Click here to Login